Age
stringclasses 73
values | Date of Data Entry
stringlengths 4
19
| Gender
stringclasses 3
values | Diagnosis
stringlengths 3
81
| Name of Drug
stringclasses 57
values | Dosage (gram)
stringclasses 28
values | Route
stringclasses 4
values | Frequency
stringclasses 6
values | Duration (days)
stringclasses 15
values | Indication
stringlengths 1
53
⌀ |
|---|---|---|---|---|---|---|---|---|---|
45
|
19/12/2019 15:38:29
|
Male
|
hepatic encephalopathy, col, upper gi bleeding
|
metronidazole
|
0.75
|
IV
|
TDS
|
1
|
col
|
45
|
19/12/2019 15:37:32
|
Male
|
hepatic encephalopathy, col, upper gi bleeding
|
ceftriaxone
|
1
|
IV
|
BD
|
2
|
col
|
66
|
19/12/2019 16:22:51
|
Male
|
alcoholic gastritis, early col, hypertension
|
amoxicillin
|
0.5
|
Oral
|
BD
|
14
|
col
|
66
|
19/12/2019 16:23:58
|
Male
|
alcoholic gastritis, early col, hypertension
|
clarithromycin
|
0.5
|
Oral
|
BD
|
14
|
col
|
48
|
19/12/2019 15:37:12
|
Female
|
he, rvi with col
|
ceftriaxone
|
1
|
IV
|
OD
|
8
|
col
|
48
|
19/12/2019 15:40:22
|
Female
|
he, rvi with col
|
levofloxacin
|
0.25
|
IV
|
OD
|
3
|
col
|
48
|
19/12/2019 15:34:56
|
Female
|
he, rvi with col
|
ceftriaxone
|
1
|
IV
|
BD
|
8
|
col
|
48
|
19/12/2019 15:38:59
|
Female
|
he, rvi with col
|
levofloxacin
|
0.5
|
IV
|
OD
|
8
|
col
|
48
|
19/12/2019 15:41:27
|
Female
|
he, rvi with col
|
rifaximin
|
0.55
|
Oral
|
BD
|
1
|
col
|
48
|
19/12/2019 14:17:07
|
Female
|
confusion, liver impairment,esophagocutaneous fistula
|
amoxicillin+flucloxacillin
|
0.5
|
Oral
|
TDS
|
7
|
confusion
|
48
|
19/12/2019 14:18:00
|
Female
|
confusion, liver impairment,esophagocutaneous fistula
|
streptomycin
|
1
|
IM
|
OD
|
1
|
confusion
|
48
|
19/12/2019 14:18:35
|
Female
|
confusion, liver impairment,esophagocutaneous fistula
|
levofloxacin
|
0.75
|
Oral
|
OD
|
1
|
confusion
|
67
|
19/12/2019 14:07:43
|
Female
|
consolidation, chest infection, aki
|
co-amoxiclav
|
1.2
|
IV
|
TDS
|
5
|
consolidation
|
67
|
19/12/2019 14:08:14
|
Female
|
consolidation, chest infection, aki
|
clarithromycin
|
0.5
|
Oral
|
BD
|
10
|
consolidation
|
63
|
19/12/2019 14:46:07
|
Male
|
acute copd, chest infection
|
ceftazidime
|
1
|
IV
|
TDS
|
4
|
copd
|
63
|
19/12/2019 14:47:41
|
Male
|
acute copd, chest infection
|
clarithromycin
|
1
|
Oral
|
BD
|
1
|
copd
|
63
|
19/12/2019 14:48:52
|
Male
|
acute copd, chest infection
|
cefixime
|
1
|
Oral
|
BD
|
7
|
copd
|
67
|
19/12/2019 16:29:26
|
Female
|
dm, copd, koch's lung, cor pulmonale
|
ceftriaxone
|
1
|
IV
|
BD
|
3
|
copd
|
67
|
19/12/2019 16:30:06
|
Female
|
dm, copd, koch's lung, cor pulmonale
|
cefixime
|
0.02
|
Oral
|
BD
|
5
|
copd
|
53
|
19/12/2019 16:16:27
|
Female
|
copd, chest infection, ihd, hypertension, newly dx dm
|
co-amoxiclav
|
1.2
|
IV
|
TDS
|
3
|
copd
|
53
|
19/12/2019 16:17:09
|
Female
|
copd, chest infection, ihd, hypertension, newly dx dm
|
ceftriaxone
|
1
|
IV
|
BD
|
2
|
copd
|
53
|
19/12/2019 16:18:06
|
Female
|
copd, chest infection, ihd, hypertension, newly dx dm
|
levofloxacin
|
0.5
|
Oral
|
OD
|
7
|
copd
|
52
|
19/12/2019 16:22:22
|
Male
|
chest infection, copd
|
ceftriaxone
|
1
|
IV
|
BD
|
4
|
copd
|
52
|
19/12/2019 16:23:50
|
Male
|
chest infection, copd
|
clarithromycin
|
0.5
|
Oral
|
BD
|
4
|
copd
|
52
|
19/12/2019 16:25:33
|
Male
|
chest infection, copd
|
co-amoxiclav
|
2
|
IV
|
TDS
|
4
|
copd
|
65
|
19/12/2019 16:22:50
|
Male
|
ccf, koch's lung, copd, chest infection, pre-diabetes
|
co-amoxiclav
|
1
|
IV
|
TDS
|
1
|
copd
|
65
|
19/12/2019 16:24:34
|
Male
|
ccf, koch's lung, copd, chest infection, pre-diabetes
|
co-amoxiclav
|
0.625
|
Oral
|
TDS
|
2
|
copd
|
65
|
19/12/2019 16:25:18
|
Male
|
ccf, koch's lung, copd, chest infection, pre-diabetes
|
clarithromycin
|
0.5
|
Oral
|
BD
|
4
|
copd
|
65
|
19/12/2019 16:25:52
|
Male
|
ccf, koch's lung, copd, chest infection, pre-diabetes
|
ceftriaxone
|
1
|
IV
|
BD
|
2
|
copd
|
74
|
19/12/2019 14:51:34
|
Female
|
copd, chest infection
|
ceftazidime
|
1
|
IV
|
TDS
|
1
|
copd
|
78
|
19/12/2019 14:00:59
|
Male
|
copd, chest infection, cardiogenic shock
|
co-amoxiclav
|
1.2
|
IV
|
TDS
|
1
|
copd
|
67
|
19/12/2019 13:56:04
|
Male
|
copd, cor pulmonale, ihd, koch’s lung
|
ceftazidime
|
1
|
IV
|
TDS
|
5
|
copd
|
58
|
19/12/2019 14:14:42
|
Male
|
copd, piles, cva
|
ceftazidime
|
1
|
IV
|
TDS
|
6
|
copd
|
78
|
19/12/2019 14:12:19
|
Male
|
lung consodilation(rlz) , COPD
|
co-amoxiclav
|
1.2
|
IV
|
TDS
|
1
|
copd
|
78
|
19/12/2019 14:13:33
|
Male
|
lung condilation(rlz), CPOD
|
clarithromycin
|
0.5
|
Oral
|
BD
|
10
|
copd
|
72
|
19/12/2019 14:37:41
|
Female
|
copd ppt chest infection, old Koch,s lung
|
co-amoxiclav
|
1.2
|
IV
|
TDS
|
1
|
copd, chest infection
|
72
|
19/12/2019 14:36:39
|
Female
|
copd ppt chest infection, koch's lung
|
ceftriaxone
|
1
|
IV
|
TDS
|
5
|
copd, chest infection
|
67
|
19/12/2019 13:56:04
|
Male
|
copd, cor pulmonale, ihd, koch’s lung
|
ceftazidime
|
1
|
IV
|
TDS
|
5
|
cor pulmonale
|
33
|
19/12/2019 16:17:27
|
Male
|
cryptococcal meningitis, pre-renal acute kidney injury, rvi stage 4
|
ceftriaxone
|
2
|
IV
|
BD
|
6
|
cryptococcal meningitis
|
33
|
19/12/2019 16:19:50
|
Male
|
cryptococcal meningitis, pre-renal acute kidney injury, rvi stage 4
|
septrin
|
0.96
|
Oral
|
OD
|
5
|
cryptococcal meningitis
|
67
|
19/12/2019 14:39:41
|
Female
|
uti , mi, dm, ckd, cuf, cff ppt by chest infection
|
ceftriaxone
|
1
|
IV
|
BD
|
7
|
cuf
|
58
|
19/12/2019 14:14:42
|
Male
|
copd, piles, cva
|
ceftazidime
|
1
|
IV
|
TDS
|
6
|
cva
|
69
|
19/12/2019 14:04:40
|
Female
|
gi bleeding, cap, right cerebral infarct, deep vein thrombosis of left leg
|
metronidazole
|
0.75
|
IV
|
TDS
|
5
|
deep vein thrombosis of left leg
|
69
|
19/12/2019 14:08:30
|
Female
|
gi bleeding, cap, right cerebral infarct, deep vein thrombosis of left leg
|
cefipime
|
1
|
IV
|
BD
|
1
|
deep vein thrombosis of left leg
|
86
|
19/12/2019 14:08:09
|
Female
|
haemoptysis, TB , degenerative mr
|
co-amoxiclav
|
1.2
|
IV
|
TDS
|
3
|
degenerative mr
|
23
|
19/12/2019 15:55:03
|
Male
|
discharge fits, dental caries, facial injury, menilly sinusitis
|
clindamycin
|
150
|
Oral
|
TDS
|
5
|
dental caries
|
23
|
19/12/2019 15:50:16
|
Male
|
discharge fits, dental caries, facial injury, menilly sinusitis
|
ceftriaxone
|
1
|
IV
|
BD
|
1
|
dental caries
|
13
|
19/12/2019 14:16:41
|
Male
|
T/T for prolong fever, dengue fever
|
ceftriaxone
|
0.5
|
IV
|
BD
|
4
|
dhf
|
13
|
19/12/2019 14:18:15
|
Male
|
T/T for prolong fever, dengue fever
|
cefixime
|
0.2
|
Oral
|
BD
|
3
|
dhf
|
13
|
19/12/2019 14:31:22
|
Male
|
DHF
|
cefixime
|
0.2
|
Oral
|
BD
|
5
|
dhf
|
14
|
19/12/2019 16:08:15
|
Male
|
dhf
|
cefixime
|
0.2
|
Oral
|
BD
|
5
|
dhf
|
13
|
19/12/2019 14:30:26
|
Male
|
DHF
|
ceftriaxone
|
1
|
IV
|
BD
|
4
|
dhf
|
15
|
19/12/2019 14:42:54
|
Male
|
dhf with warning signs
|
ceftriaxone
|
1
|
IV
|
BD
|
7
|
dhf
|
15
|
19/12/2019 14:45:38
|
Male
|
dhf with warning signs
|
metronidazole
|
0.75
|
IV
|
TDS
|
7
|
dhf
|
23
|
19/12/2019 15:55:03
|
Male
|
discharge fits, dental caries, facial injury, menilly sinusitis
|
clindamycin
|
150
|
Oral
|
TDS
|
5
|
discharge fits
|
23
|
19/12/2019 15:50:16
|
Male
|
discharge fits, dental caries, facial injury, menilly sinusitis
|
ceftriaxone
|
1
|
IV
|
BD
|
1
|
discharge fits
|
29
|
19/12/2019 15:11:11
|
Female
|
discharge uti
|
ciprofloxacin
|
0.5
|
Oral
|
OD
|
1
|
discharge uti
|
41
|
19/12/2019 15:47:25
|
Male
|
right leg cellulitis, col, duodenal erosion, rvi satge
|
amoxicillin+flucoxacillin
|
0.5
|
Oral
|
TDS
|
5
|
duodenal erosion
|
41
|
19/12/2019 15:43:49
|
Male
|
right leg cellulitis, col, duodenal erosion, rvi stage 2
|
amoxicillin+flucloxacillin
|
1
|
IV
|
QID
|
8
|
duodenal erosion
|
41
|
19/12/2019 15:46:19
|
Male
|
right leg cellulitis, col, duodenal erosion, rvi satge 2
|
clindamycin
|
0.5
|
Oral
|
TDS
|
1
|
duodenal erosion
|
90
|
19/12/2019 15:04:30
|
Female
|
sick sinus syndrome, ccf, poor drug adherence, ihd
|
ceftriaxone
|
1
|
IV
|
BD
|
4
|
dyspnoea
|
30
|
19/12/2019 15:03:36
|
Female
|
rhd, severe ms, mild tr, severe pol ht, large slot in la, on warfarinization
|
pen v
|
0.25
|
Oral
|
BD
|
1
|
dyspnoea
|
90
|
19/12/2019 15:08:08
|
Female
|
sick sinus syndrome, ccf, poor drug adherence, ihd
|
cefixime
|
0.2
|
Oral
|
BD
|
3
|
dyspnoea
|
19
|
19/12/2019 16:18:07
|
Male
|
electrocution left hand
|
amoxicillin+flucloxacillin
|
0.25
|
Oral
|
TDS
|
5
|
electrocution left hand
|
54
|
19/12/2019 14:45:52
|
Female
|
hydropneumothorax, empyema, type 2 dm, myoma uterus
|
metronidazole
|
0.75
|
IV
|
TDS
|
1
|
empyema
|
54
|
19/12/2019 14:47:44
|
Female
|
hydropneumothorax, empyema, type 2 dm, myoma uterus
|
co-amoxiclav
|
1.2
|
IV
|
TDS
|
14
|
empyema
|
48
|
19/12/2019 14:17:07
|
Female
|
confusion, liver impairment,esophagocutaneous fistula
|
amoxicillin+flucloxacillin
|
0.5
|
Oral
|
TDS
|
7
|
esophagocutaneous fistula
|
48
|
19/12/2019 14:18:00
|
Female
|
confusion, liver impairment,esophagocutaneous fistula
|
streptomycin
|
1
|
IM
|
OD
|
1
|
esophagocutaneous fistula
|
48
|
19/12/2019 14:18:35
|
Female
|
confusion, liver impairment,esophagocutaneous fistula
|
levofloxacin
|
0.75
|
Oral
|
OD
|
1
|
esophagocutaneous fistula
|
52
|
19/12/2019 15:35:57
|
Male
|
ESRD
|
cefixime
|
0.2
|
Oral
|
BD
|
5
|
esrd
|
52
|
19/12/2019 15:37:25
|
Male
|
esrd
|
co-amoxiclav
|
0.6
|
Oral
|
OD
|
1
|
esrd
|
52
|
19/12/2019 15:39:08
|
Male
|
esrd
|
co-amoxiclav
|
1.2
|
IV
|
OD
|
1
|
esrd
|
52
|
19/12/2019 15:42:06
|
Male
|
esrd
|
ceftriaxone+sulbactam
|
1
|
IV
|
BD
|
4
|
esrd
|
38
|
19/12/2019 15:26:31
|
Male
|
alcohol withdrawal, extensive koch's lung, septic shock ē lrti
|
cefoparazone+sulbactam
|
2
|
IV
|
BD
|
10
|
extensive koch's lung
|
23
|
19/12/2019 15:55:03
|
Male
|
discharge fits, dental caries, facial injury, menilly sinusitis
|
clindamycin
|
150
|
Oral
|
TDS
|
5
|
facial injury
|
23
|
19/12/2019 15:50:16
|
Male
|
discharge fits, dental caries, facial injury, menilly sinusitis
|
ceftriaxone
|
1
|
IV
|
BD
|
1
|
facial injury
|
19
|
19/12/2019 15:09:44
|
Female
|
avi
|
ceftriaxone
|
1
|
IV
|
BD
|
2
|
fainting attack
|
28
|
19/12/2019 14:10:33
|
Male
|
febrile convulsion d/t avi
|
cefixime
|
0.06
|
Oral
|
BD
|
1
|
febrile convulsion d/t avi
|
1
|
19/12/2019 16:00:42
|
Male
|
fever with malaena
|
flucloxacillin
|
0.125
|
Oral
|
BD
|
1
|
fever
|
22
|
19/12/2019 16:19:10
|
Male
|
fever with capopedal spasm
|
ceftriaxone
|
1
|
IV
|
BD
|
3
|
fever
|
22
|
19/12/2019 16:19:52
|
Male
|
fever with capopedal spasm
|
cefixime
|
0.2
|
Oral
|
BD
|
5
|
fever
|
70
|
19/12/2019 15:46:17
|
Male
|
avi
|
ceftriaxone
|
2
|
IV
|
BD
|
7
|
fever
|
70
|
19/12/2019 15:47:31
|
Male
|
avi
|
levofloxacin
|
0.25
|
IV
|
OD
|
7
|
fever
|
70
|
19/12/2019 15:48:18
|
Male
|
avi
|
metronidazole
|
0.75
|
IV
|
TDS
|
7
|
fever
|
63
|
19/12/2019 13:58:49
|
Female
|
fever, dyspnoea
|
imipenem
|
0.5
|
IV
|
TDS
|
7
|
fever
|
22
|
19/12/2019 15:13:40
|
Male
|
malaria
|
ceftriaxone
|
1
|
IV
|
BD
|
4
|
fever
|
22
|
19/12/2019 15:14:19
|
Male
|
malaria
|
doxycycline
|
0.1
|
Oral
|
BD
|
7
|
fever
|
19
|
19/12/2019 14:58:55
|
Male
|
avi
|
co-amoxiclav
|
0.625
|
Oral
|
TDS
|
3
|
fever
|
70
|
19/12/2019 14:04:55
|
Female
|
neutropenia, fever, anaemia, ca buffalo mucosa, type 2 dm
|
ceftriaxone
|
1
|
IV
|
BD
|
2
|
fever
|
70
|
19/12/2019 14:05:42
|
Female
|
neutropenia, fever, anaemia, ca buffalo mucosa, type 2 dm
|
amikacin
|
0.5
|
IV
|
BD
|
8
|
fever
|
70
|
19/12/2019 14:06:17
|
Female
|
neutropenia, fever, anaemia, ca buffalo mucosa, type 2 dm
|
ceftazidime
|
2
|
IV
|
TDS
|
2
|
fever
|
48
|
19/12/2019 15:41:27
|
Female
|
he, rvi with col
|
rifaximin
|
0.55
|
Oral
|
BD
|
1
|
fever
|
15
|
19/12/2019 15:07:34
|
Male
|
flaccid paraparesis
|
amoxicillin+flucloxacillin
|
0.5
|
Oral
|
QID
|
1
|
flaccid paraparesis
|
32
|
19/12/2019 14:35:20
|
Male
|
food poisoing, acute GE, some dehydration
|
norfloxacin
|
0.4
|
Oral
|
BD
|
3
|
food poisoing
|
47
|
19/12/2019 15:15:38
|
Male
|
centipede bite
|
amoxicillin+flucloxacillin
|
0.5
|
Oral
|
TDS
|
1
|
for killing according bacteria
|
43
|
19/12/2019 15:32:12
|
Male
|
hma, dm, dkd
|
clarithromycin
|
0.5
|
Oral
|
BD
|
14
|
for ogd scopy
|
43
|
19/12/2019 15:33:08
|
Male
|
hma, dm, dkd
|
amoxiclav
|
1
|
Oral
|
BD
|
14
|
for ogd scopy
|
53
|
19/12/2019 14:48:01
|
Male
|
b(+), col, gastritis
|
ceftriaxone
|
1
|
IV
|
BD
|
1
|
gastritis
|
32
|
19/12/2019 16:14:45
|
Female
|
general debility e excessive vomitting, uraemic gastritis, hcv aki ckd, retro(+)
|
co-amoxiclav
|
1.2
|
IV
|
TDS
|
2
|
general debility e excessive vomitting
|
32
|
19/12/2019 16:15:20
|
Female
|
general debility e excessive vomitting, uraemic gastritis, hcv aki ckd, retro(+)
|
co-amoxiclav
|
0.6
|
Oral
|
OD
|
2
|
general debility e excessive vomitting
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.